RBC sales increase
This article was originally published in The Tan Sheet
First-quarter net sales for RBC Life Sciences increased 18 percent to $6.35 million, the Irving, Texas-based firm announces May 5. Net earnings for the January-March period increased 9 percent to $355,000 compared to $325,000 last year, nutritional supplements manufacturer says. The firm, which specializes in introducing nanotechnology into nutritional and personal care products, says its nutritional segment grew more than 14 percent compared to the year-ago quarter due to an increase in revenues from its international licensees...
You may also be interested in...
ABHI’s Phil Brown believes the future of UK device regulation will be innovation-friendly and patient-responsive system – but doesn’t expect easy alignment with the EU. See what he had to say.
Biologics license application is preferred route to market, but if emergency authorization is given it should happen with full transparency and be communicated in a clear manner to strengthen public confidence, National Vaccine Advisory Committee says.
With the meetings available on television, access can be assured for just about everyone, and the US FDA can avoid another gut punch to its credibility.